{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:40:39Z","timestamp":1792928439150,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12201077"],"award-info":[{"award-number":["12201077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtbi.2026.112450","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:51:09Z","timestamp":1774486269000},"page":"112450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modeling HIV dynamics under broadly neutralizing antibodies: The potential role of cell-to-cell virus transmission"],"prefix":"10.1016","volume":"626","author":[{"given":"Ting","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2293-9352","authenticated-orcid":false,"given":"Zhaozong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9052-7428","authenticated-orcid":false,"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.jtbi.2026.112450_bib0001","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2026.112450_bib0002","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of fc\u2212fc\u03b3r interactions in igg-mediated microbial neutralization","volume":"212","author":"Bournazos","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtbi.2026.112450_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10844","article-title":"Elimination of HIV-1-infected cells by broadly neutralizing antibodies","volume":"7","author":"Bruel","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jtbi.2026.112450_bib0004","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1172\/JCI134395","article-title":"Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound","volume":"130","author":"Cale","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtbi.2026.112450_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.710012","article-title":"Modeling HIV-1 within-host dynamics after passive infusion of the broadly neutralizing antibody VRC01","volume":"12","author":"Cardozo-Ojeda","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jtbi.2026.112450_bib0006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10\u20131074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jtbi.2026.112450_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011518","article-title":"Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1","volume":"20","author":"Cassidy","year":"2024","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0008","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1128\/JVI.79.7.4140-4149.2005","article-title":"Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.jtbi.2026.112450_bib0009","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1073\/pnas.1419162112","article-title":"Post-treatment control of HIV infection","volume":"112","author":"Conway","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtbi.2026.112450_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2023.113702","article-title":"Modeling the cytotoxicity of romidepsin reveals the ineffectiveness of this drug in the \u201cshock and kill\u201d strategy","volume":"173","author":"Deng","year":"2023","journal-title":"Chaos. Soliton Fract."},{"key":"10.1016\/j.jtbi.2026.112450_bib0011","article-title":"Single-chain variable fragments of broadly neutralizing antibodies prevent HIV cell-cell transmission","volume":"96","author":"Dorsten","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0012","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12977-018-0434-1","article-title":"HIV-1 cell-to-cell transmission and broadly neutralizing antibodies","volume":"15","author":"Dufloo","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.jtbi.2026.112450_bib0013","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/JVI.03245-13","article-title":"High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse","volume":"88","author":"Duncan","year":"2014","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.jtbi.2026.112450_bib0014","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1128\/JVI.00306-16","article-title":"Notwithstanding circumstantial alibis, cytotoxic T cells can be major killers of HIV-1-infected cells","volume":"90","author":"Gadhamsetty","year":"2016","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.jtbi.2026.112450_bib0015","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.celrep.2019.11.030","article-title":"Preferential presentation of high-affinity immune complexes in germinal centers can explain how passive immunization improves the humoral response","volume":"29","author":"Garg","year":"2019","journal-title":"Cell. Reports"},{"issue":"1","key":"10.1016\/j.jtbi.2026.112450_bib0016","article-title":"Basis and statistical design of the passive HIV-1 antibody mediated prevention (AMP) test-of-concept efficacy trials","volume":"9","author":"Gilbert","year":"2017","journal-title":"Stat. Commun. Infect. Dis."},{"key":"10.1016\/j.jtbi.2026.112450_bib0017","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1128\/JVI.00783-15","article-title":"Inhibitory effect of individual or combinations of broadly neutralizing antibodies and antiviral reagents against cell-free and cell-to-cell HIV-1 transmission","volume":"89","author":"Gombos","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0018","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-virology-110615-042249","article-title":"Modeling viral spread","volume":"3","author":"Graw","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0019","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1038\/s41598-017-03954-9","article-title":"Number of infection events per cell during HIV-1 cell-free infection","volume":"7","author":"Gritoaw","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtbi.2026.112450_bib0020","first-page":"3631","article-title":"HIV infection dynamics with broadly neutralizing antibodies and CTL immune response","volume":"18","author":"Guo","year":"2025","journal-title":"Discrete Cont. Dyn-S."},{"key":"10.1016\/j.jtbi.2026.112450_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2020.110502","article-title":"Modeling HIV multiple infection","volume":"509","author":"Guo","year":"2021","journal-title":"J. Theor. Biol."},{"issue":"4","key":"10.1016\/j.jtbi.2026.112450_bib0022","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nm.4063","article-title":"Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques","volume":"22","author":"Hessell","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtbi.2026.112450_bib0023","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/01.qai.0000199233.69457.e4","article-title":"Density-dependent decay in HIV-1 dynamics","volume":"41","author":"Holte","year":"2006","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"10.1016\/j.jtbi.2026.112450_bib0024","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"Huang","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jtbi.2026.112450_bib0025","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/19420862.2017.1311435","article-title":"Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults","volume":"9","author":"Huang","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.jtbi.2026.112450_bib0026","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08150","article-title":"Cell-to-cell infection by HIV contributes over half of virus infection","volume":"4","author":"Iwami","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.jtbi.2026.112450_bib0027","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/418144a","article-title":"Recombination: multiply infected spleen cells in HIV patients","volume":"418","author":"Jung","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112450_bib0028","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing anti-bodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112450_bib0029","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"Kong","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0030","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76004","article-title":"Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1","volume":"11","author":"Lamont","year":"2022","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.jtbi.2026.112450_bib0031","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cei.12692","article-title":"Pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults","volume":"182","author":"Ledgerwood","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0032","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/COH.0000000000000439","article-title":"Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?","volume":"13","author":"Lee","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jtbi.2026.112450_bib0033","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/JVI.02425-16","article-title":"Reduced potency and incomplete neutralization of broadly neutralizing antibodies against cell-to-cell transmission of HIV-1 with transmitted founder envs","volume":"91","author":"Li","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0034","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112450_bib0035","series-title":"Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities","volume":"Vol. 9","author":"Liu","year":"2020"},{"issue":"4","key":"10.1016\/j.jtbi.2026.112450_bib0036","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00285-011-0474-9","article-title":"Threshold virus dynamics with impulsive antiretroviral drug effects","volume":"65","author":"Lou","year":"2012","journal-title":"J. Math. Biol."},{"issue":"6288","key":"10.1016\/j.jtbi.2026.112450_bib0037","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.jtbi.2026.112450_bib0038","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci. Trans. Med."},{"issue":"4","key":"10.1016\/j.jtbi.2026.112450_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010003","article-title":"Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention","volume":"18","author":"Mayer","year":"2022","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12977-014-0083-y","article-title":"Neutralisation of HIV-1 cell-cell spread by human and llama antibodies","volume":"11","author":"Mccoy","year":"2014","journal-title":"Retrovirology"},{"issue":"30","key":"10.1016\/j.jtbi.2026.112450_bib0041","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104651118","article-title":"Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody","volume":"118","author":"Meijers","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7646","key":"10.1016\/j.jtbi.2026.112450_bib0042","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature21435","article-title":"Early antibody therapy can induce long-lasting immunity to SHIV","volume":"543","author":"Nishimura","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112450_bib0043","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2017.07.010","article-title":"Of mice, macaques, and men: broadly neutralizing antibody immunotherapy for HIV-1","volume":"22","author":"Nishimura","year":"2017","journal-title":"Cell. Host. Microbe"},{"key":"10.1016\/j.jtbi.2026.112450_bib0044","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/imr.12511","article-title":"Use of broadly neutralizing antibodies for HIV-1 prevention","volume":"275","author":"Pegu","year":"2017","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.jtbi.2026.112450_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007626","article-title":"Mathematical modeling to reveal breakthrough mechanisms in the HIV antibody mediated prevention (AMP) trials","volume":"16","author":"Reeves","year":"2020","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.jtbi.2026.112450_bib0046","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1038\/s41467-023-43384-y","article-title":"High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the antibody mediated prevention trials","volume":"14","author":"Reeves","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtbi.2026.112450_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004966","article-title":"Capacity of broadly neutralizing antibodies to inhibit HIV-1 cell-cell transmission is strain- and epitope-dependent","volume":"11","author":"Reh","year":"2015","journal-title":"PLoS Pathog."},{"issue":"22","key":"10.1016\/j.jtbi.2026.112450_bib0048","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1056\/NEJMoa1508952","article-title":"Prospective study of acute HIV-1 infection in adults in east Africa and Thailand","volume":"374","author":"Robb","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jtbi.2026.112450_bib0049","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.3934\/mbe.2023538","article-title":"The role of cell-to-cell transmission in HIV infection: insights from a mathematical modeling approach","volume":"20","author":"Rong","year":"2023","journal-title":"Math. Biosci. Eng."},{"key":"10.1016\/j.jtbi.2026.112450_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008434","article-title":"Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection","volume":"16","author":"Saha","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jtbi.2026.112450_bib0051","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2014.00289","article-title":"Which antibody functions are important for an HIV vaccine?","volume":"5","author":"Su","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jtbi.2026.112450_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005520","article-title":"Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C infection","volume":"12","author":"Wagh","year":"2016","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.jtbi.2026.112450_bib0053","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10884-008-9111-8","article-title":"Threshold dynamics for compartmental epidemic models in periodic environments","volume":"20","author":"Wang","year":"2008","journal-title":"J. Dyn. Differ. Equ."},{"key":"10.1016\/j.jtbi.2026.112450_bib0054","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.jtbi.2026.112450_bib0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.nonrwa.2011.07.028","article-title":"Threshold dynamics for compartmental epidemic models with impulses, nonlinear anal","volume":"13","author":"Yang","year":"2012","journal-title":"Real World Appl."},{"issue":"5","key":"10.1016\/j.jtbi.2026.112450_bib0056","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11538-013-9831-8","article-title":"Pulse HIV vaccination: feasibility for virus eradication and optimal vaccination schedule","volume":"75","author":"Yang","year":"2013","journal-title":"Bull. Math. Biol."},{"issue":"5993","key":"10.1016\/j.jtbi.2026.112450_bib0057","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"Zhou","year":"2010","journal-title":"Sci. (New York, N.Y.)"}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519326000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519326000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:14:29Z","timestamp":1776183269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519326000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"alternative-id":["S0022519326000755"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112450","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling HIV dynamics under broadly neutralizing antibodies: The potential role of cell-to-cell virus transmission","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112450"}}